Nidhi ShettyStark / Raving Health, a leading clinical trial marketing agency specializing in patient recruitment, is pleased to announce the addition of Nidhi Shetty to our team as Junior Media Analyst. This strategic hire marks a significant step in the expansion of our media department, reinforcing our commitment to excellence and innovation in clinical trial marketing.

As a Junior Media Analyst, Nidhi will play a role in analyzing media trends, identifying opportunities for growth and optimizations, enhancing reporting capabilities, and contributing to the success of our patient recruitment media campaigns. Nidhi’s unique skills and insights will enhance our capabilities in helping our clients navigate the dynamic landscape of clinical research.

“Our decision to expand our media department comes as a response to the increasing demand for comprehensive and strategic media solutions that accelerate clinical trial enrollment efforts,” said Stephen Eustace, Director, Digital Media Strategy at Stark / Raving Health. “Nidhi addition to our team aligns perfectly with our commitment to delivering high-impact clinical trial marketing strategies to Sponsors and CROs.”

Stark / Raving Health is dedicated to providing cutting-edge study branding, materials, websites, and media outreach solutions tailored to the unique requirements of each clinical trial and patient recruitment goal. This expansion will allow us to further strengthen our position as a leading clinical trial marketing agency for patient recruitment, offering clients unmatched media expertise and support throughout their trials.

About Stark / Raving Health
Stark / Raving Health is an independently owned patient recruitment agency that accelerates global clinical trial enrollment using engaging study toolkits, patient-centric digital experiences, and targeted media outreach campaigns. Our approach is built on 20+ years of successfully delivering hundreds of patient recruitment campaigns across a range of therapeutic areas in more than 40 countries and over 70 languages. Our ability to scale our streamlined approach and successfully deliver patients has made us a go-to resource for the world’s leading biotechs, pharmaceutical companies, and CROs.

To learn more, visit